Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX1 | P07099 | 10/20 | 0.59 |
| ▸ | ZDHHC20 | Q5W0Z9 | 1/20 | 0.55 |
| ▸ | ZDHHC2 | Q9UIJ5 | 1/20 | 0.55 |
| ▸ | CASP2 | P42575 | 1/20 | 0.53 |
| ▸ | PLA2G2A | P14555 | 2/20 | 0.53 |
| ▸ | FAAH | O00519 | 1/20 | 0.50 |
| ▸ | NAAA | Q02083 | 1/20 | 0.50 |
| ▸ | PLA2G4A | P47712 | 1/20 | 0.49 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.48 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.48 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.48 |
| ▸ | DPP7 | Q9UHL4 | 1/20 | 0.47 |
| ▸ | TSHR | P16473 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL146327 | 1.00 | EPHX1 (0.59) | EPHX1ZDHHC20ZDHHC2CASP2PLA2G2A | |
| SCHEMBL149423 | 1.00 | EPHX1 (0.59) | EPHX1ZDHHC20ZDHHC2CASP2PLA2G2A | |
| SCHEMBL150597 | 1.00 | EPHX1 (0.59) | EPHX1ZDHHC20ZDHHC2CASP2PLA2G2A | |
| SCHEMBL153838 | 1.00 | EPHX1 (0.59) | EPHX1ZDHHC20ZDHHC2CASP2PLA2G2A | |
| SCHEMBL148656 | 1.00 | EPHX1 (0.59) | EPHX1ZDHHC20ZDHHC2CASP2PLA2G2A | |
| SCHEMBL148882 | 1.00 | EPHX1 (0.59) | EPHX1ZDHHC20ZDHHC2CASP2PLA2G2A | |
| SCHEMBL149561 | 1.00 | EPHX1 (0.59) | EPHX1ZDHHC20ZDHHC2CASP2PLA2G2A | |
| SCHEMBL146693 | 1.00 | EPHX1 (0.59) | EPHX1ZDHHC20ZDHHC2CASP2PLA2G2A | |
| SCHEMBL149350 | 1.00 | EPHX1 (0.59) | EPHX1ZDHHC20ZDHHC2CASP2PLA2G2A | |
| SCHEMBL144546 | 1.00 | EPHX1 (0.59) | EPHX1ZDHHC20ZDHHC2CASP2PLA2G2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 45 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3983462-A1 | AQUEOUS POLYMER DISPERSIONS SUITABLE AS OPACIFIERS IN LIQUID FORMULATIONS | BASF SE (DE) | 2022-04-20 | — | — | EP | disclosed |
| US-20210292457-A1 | AQUEOUS POLYMER DISPERSION | BASF SE (DE) | 2021-09-23 | — | — | US | disclosed |
| WO-2020249706-A1 | AQUEOUS POLYMER DISPERSIONS SUITABLE AS OPACIFIERS IN LIQUID FORMULATIONS | BASF SE (DE) | 2020-12-17 | — | — | WO | disclosed |
| EP-3746488-A1 | A PROCESS FOR THE PREPARATION OF A POLYMER COMPOSITION | BASF SE (DE) | 2020-12-09 | — | — | EP | disclosed |
| US-20200362070-A1 | A Process for the Preparation of a Polymer Composition | BASF SE (DE) | 2020-11-19 | — | — | US | disclosed |
| EP-3491029-B1 | AQUEOUS POLYMER DISPERSION | BASF SE (DE) | 2020-05-20 | — | — | EP | disclosed |
| US-10655088-B2 | Solid polymer composition obtained by polymerization of an acid group-containing monomer in the presence of a polyether compound | BASF SE (DE) | 2020-05-19 | — | — | US | disclosed |
| US-20200086616-A1 | MULTI-LAYERED FILM , METHOD FOR THE PRODUCTION AND USE THEREOF | BASF SE (DE) | 2020-03-19 | — | — | US | disclosed |
| US-20200079922-A1 | METHOD FOR PRODUCING FUNCTIONAL WATER SOLUBLE FILMS | BASF SE (DE) | 2020-03-12 | — | — | US | disclosed |
| US-20190249116-A1 | SOLID POLYMER COMPOSITION OBTAINED BY POLYMERIZATION OF AN ACID GROUP-CONTAINING MONOMER IN THE PRESENCE OF A POLYETHER COMPOUND | BASF SE (DE) | 2019-08-15 | — | — | US | disclosed |
| US-20110312240-A1 | AQUEOUS BINDER COMPOSITIONS | BASF SE (DE) | 2011-12-22 | — | — | US | disclosed |
| US-20110257302-A1 | BINDER COMPOSITIONS COMPRISING BORIC ACID OR BORIC ACID SALT | BASF SE (DE) | 2011-10-20 | — | — | US | disclosed |
| US-20110009540-A1 | POLYMER DISPERSIONS CONTAINING PHOSPHOROUS POLYMERS AND EMULSIFIERS | BASF SE (DE) | 2011-01-13 | — | — | US | disclosed |
| US-20100068156-A1 | AMPHOLYTIC COPOLYMER BASED ON QUATERNIZED NITROGEN-CONTAINING MONOMERS | BASF SE (DE) | 2010-03-18 | — | — | US | disclosed |
| EP-2064253-B1 | AMPHOLYTIC COPOLYMER BASED ON QUATERNIZED NITROGEN-CONTAINING MONOMERS | BASF SE (DE) | 2009-11-18 | — | — | EP | disclosed |
| WO-2009103735-A1 | COMPOSITION CONTAINING AN AMPHOLYTIC COPOLYMER ON THE BASIS OF QUATERNISED MONOMERS CONTAINING NITROGEN AND AT LEAST ONE POLYMER THAT DIFFERS FROM SAID COPOLYMER, AND USE THEREOF | BASF SE (DE) | 2009-08-27 | — | — | WO | disclosed |
| EP-2064253-A1 | AMPHOLYTIC COPOLYMER BASED ON QUATERNIZED NITROGEN-CONTAINING MONOMERS | BASF SE (DE) | 2009-06-03 | — | — | EP | disclosed |
| US-20080219934-A1 | Anionic, Ampholytic Copolymers for Low-Voc-Compositions | BASF AKTIENGESELLSCHAFT (DE) | 2008-09-11 | — | — | US | disclosed |
| US-20080194708-A1 | Cationic Polymers as Thickeners for Aqueous and Alcoholic Compositions | BASF AKTIENGESELLSCHAFT (DE) | 2008-08-14 | — | — | US | disclosed |
| WO-2008031892-A1 | AMPHOLYTIC COPOLYMER BASED ON QUATERNIZED NITROGEN-CONTAINING MONOMERS | BASF SE (DE) | 2008-03-20 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080194708-A1 | Cationic Polymers as Thickeners for Aqueous and Alcoholic Compositions | ADH1A, ADH1C, PCNA | EPHX1 885/4885ZDHHC20 1626/4885ZDHHC2 2045/4885 |
| US-20190249116-A1 | SOLID POLYMER COMPOSITION OBTAINED BY POLYMERIZATION OF AN ACID GROUP-CONTAINING MONOMER IN THE PRESENCE OF A POLYETHER COMPOUND | PCCA, EEF1D, COPE | EPHX1 177/4885ZDHHC20 1530/4885ZDHHC2 1202/4885 |
| US-10655088-B2 | Solid polymer composition obtained by polymerization of an acid group-containing monomer in the presence of a polyether compound | PCCA, EEF1D, COPE | EPHX1 177/4885ZDHHC20 1530/4885ZDHHC2 1202/4885 |
| US-20100068156-A1 | AMPHOLYTIC COPOLYMER BASED ON QUATERNIZED NITROGEN-CONTAINING MONOMERS | NGLY1, NAAA, NIT2 | EPHX1 2350/4885ZDHHC20 3930/4885ZDHHC2 4198/4885 |
| US-20080219934-A1 | Anionic, Ampholytic Copolymers for Low-Voc-Compositions | ABHD16A, APEH, ABHD5 | EPHX1 398/4885ZDHHC20 1243/4885ZDHHC2 1454/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.